INCREDB ID : 128
Home >> Investigator Page Previous      Next
Rama Devi Mittal, Ph.D.
Additional Professor 
 
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Department of Urology
Raebareli Road
Lucknow - 226 014   
Uttar Pradesh   
 
E-mail: rdmittal@sgpgi.ac.in, ramamittal@yahoo.com
 
Area of Specialization:
Urology
Publications:
1. Mittal, R. D., Srivastava, P., Singh, V., Jaiswal, P. and Kapoor, R.  Association of Common Variants of Vascular Endothelial Growth Factor and Interleukin-18 Genes with Allograft Survival in Renal Transplant Recipients of North India. DNA and Cell Biology. 2011.  [PubMed]
2. Mandal, R. K. and Mittal, R. D.  Comment on "Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer" by Weng et al., Oral Oncol 46 (2010) 767-772. Institute of Medical Sciences, Raebareli Rd., Lucknow 226014, India. Oral Oncology. 2011.  [PubMed]
3. Ahirwar, D. K., Kesarwani, P., Singh, R., Ghoshal, U. C. and Mittal, R. D.  Role of Tumor Necrosis Factor-Alpha (C-863A) Polymorphism in Pathogenesis of Journal of Gastrointestinal Cancer. 2011.  [PubMed]
4. George, G. P. and Mittal, R. D.  Caspase 8 gene variants in healthy North Indian population and comparison with worldwide ethnic group variations. Indian Journal of Human Genetics. 2010.  16, 144-148. [PubMed]
5. Pandey, S., Mittal, B., Srivastava, M., Singh, S., Srivastava, K., Lal, P. and Mittal, R. D.  Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Molecular Biology Reports. 2010.  [PubMed]
6. George, G. P., Gangwar, R., Mandal, R. K., Sankhwar, S. N. and Mittal, R. D.  Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Molecular Biology Reports. 2011.  38, 1609-1615. [PubMed]
7. Srivastava, P., Gangwar, R., Kapoor, R. and Mittal, R. D.  Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Disease Markers. 2010.  29, 37-46. [PubMed]
8. Mandal, R. K. and Mittal, R. D.  Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population? Urologic Oncology. 2010.  [PubMed]
9. Kesarwani, P., Mandal, R. K., Maheshwari, R. and Mittal, R. D.  Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU International. 2011.  107, 471-476. [PubMed]
10. Pandey, S., Mittal, R. D., Srivastava, M., Srivastava, K. and Mittal, B.  Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population. International Journal of Gynecological Cancer. 2010.  20, 625-630. [PubMed]
11. Malik, M. A., Upadhyay, R., Mittal, R. D., Zargar, S. A. and Mittal, B.  Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutrition and Cancer. 2010.  62, 734-742. [PubMed]
12. Gangwar, R., Mandhani, A. and Mittal, R. D.  Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery. 2011.  149, 126-134. [PubMed]
13. Mandal, R. K., Kapoor, R. and Mittal, R. D.  Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population. DNA and Cell Biology. 2010.  29, 669-674. [PubMed]
14. Srivastava, P., Mandhani, A., Kapoor, R. and Mittal, R. D.  Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort. Annals of Surgical Oncology. 2010.  17, 3068-3075. [PubMed]
15. Singh, R., Srivastava, A., Kapoor, R. and Mittal, R. D.  Do Drug Transporter (ABCB1) SNPs Influence Cyclosporine and Tacrolimus Dose Requirements and Renal Allograft Outcome in the Posttransplantation Period? Journal of Clinical Pharmacology. 2010.  [PubMed]
16. Ahirwar, D. K., Mandhani, A. and Mittal, R. D.  IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Archives of Medical Research. 2010.  41, 97-103. [PubMed]
17. Gangwar, R. and Mittal, R. D.  Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA and Cell Biology. 2010.  29, 349-356. [PubMed]
18. Gangwar, R., Mittal, B., Srivastava, S., Singh, H. and Mittal, R. D.  Genetic variants of DNA repair gene XPC modulating susceptibility to cervical cancer in North India. Oncology Research. 2010.  18, 329-335. [PubMed]
19. Singh, R., Srivastava, P., Srivastava, A. and Mittal, R. D.  Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients. Nephrology, Dialysis, Transplantation. 2010.  25, 3393-3401. [PubMed]
20. Mandal, R. K., Gangwar, R., Mandhani, A. and Mittal, R. D.  DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India. DNA and Cell Biology. 2010.  29, 183-190. [PubMed]
21. Gangwar, R., Mandhani, A. and Mittal, R. D.  XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Journal of Cancer Research and Clinical Oncology. 2010.  136, 779-786. [PubMed]
22. Kesarwani, P., Mandhani, A. and Mittal, R. D.  Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort. The Journal of Urology. 2009.  182, 2938-2943. [PubMed]
23. Gangwar, R., Ahirwar, D., Mandhani, A. and Mittal, R. D.  Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutation Research. 2009.  680, 56-63. [PubMed]
24. Manchanda, P. K., Kumar, A., Sharma, R. K., Goel, H. and Mittal, R. D.  Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels. Biologics : Targets & Therapy. 2008.  2, 875-884. [PubMed]
25. Gangwar, R., Pandey, S. and Mittal, R. D.  Association of interferon-gamma +874A polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG : An International Journal of Obstetrics and Gynaecology. 2009.  116, 1671-1677. [PubMed]
26. Pandey, S., Mittal, R. D., Srivastava, M., Srivastava, K., Singh, S., Srivastava, S. and Mittal, B.  Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecologic Oncology. 2009.  114, 501-505. [PubMed]
27. Malik, M. A., Upadhyay, R., Mittal, R. D., Zargar, S. A., Modi, D. R. and Mittal, B.  Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. Journal of Gastrointestinal Cancer. 2009.  40, 26-32. [PubMed]
28. Ahirwar, D. K., Agrahari, A., Mandhani, A. and Mittal, R. D.  Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility To Chemicals. 2009.  14, 213-218. [PubMed]
29. Singh, R., Manchanda, P. K., Kesarwani, P., Srivastava, A. and Mittal, R. D.  Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients. Clinical Transplantation. 2009.  23, 490-498. [PubMed]
30. Gangwar, R., Mandhani, A. and Mittal, R. D.  Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Annals of Surgical Oncology. 2009.  16, 2028-2034. [PubMed]
31. Mittal, R. D., Kesarwani, P., Singh, R., Ahirwar, D. and Mandhani, A.  GSTM1, GSTM3 and GSTT1 gene variants and risk of benign prostate hyperplasia in North India. Disease Markers. 2009.  26, 85-91. [PubMed]
32. Ahirwar, D. K., Mandhani, A., Dharaskar, A., Kesarwani, P. and Mittal, R. D.  Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy. BJU International. 2009.  104, 867-873. [PubMed]
33. Gangawar, R., Ahirwar, D., Mandhani, A. and Mittal, R. D.  Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India. Medical Oncology. 2010.  27, 159-166. [PubMed]
34. Ahirwar, D., Mandhani, A. and Mittal, R. D.  Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Archives of Medical Research. 2009.  40, 97-102. [PubMed]
35. Manchanda, P. K., Singh, R. and Mittal, R. D.  Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease. DNA and Cell Biology. 2009.  28, 177-183. [PubMed]
36. Singh, R., Kesarwani, P., Ahirwar, D. K., Kapoor, R. and Mittal, R. D.  Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India. Transplant Immunology. 2009.  21, 13-17. [PubMed]
37. Kesarwani, P., Ahirwar, D. K., Mandhani, A., Singh, A. N., Dalela, D., Srivastava, A. N. and Mittal, R. D.  IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World Journal of Urology. 2009.  27, 389-396. [PubMed]
38. Gangwar, R., Ahirwar, D., Mandhani, A. and Mittal, R. D.  Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India. Urology. 2009.  73, 675-680. [PubMed]
39. Singh, R., Kapoor, R., Srivastava, A. and Mittal, R. D.  Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients. Scandinavian Journal of Immunology. 2009.  69, 51-56. [PubMed]
40. Gangwar, R., Manchanda, P. K. and Mittal, R. D.  Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica. 2009.  136, 163-169. [PubMed]
41. Singh, R., Kesarwani, P., Srivastava, A. and Mittal, R. D.  ABCB1 G2677 allele is associated with high dose requirement of cyclosporin A to prevent renal allograft rejection in North India. Archives of Medical Research. 2008.  39, 695-701. [PubMed]
42. Kesarwani, P., Ahirwar, D. K., Mandhani, A. and Mittal, R. D.  Association between -174 G/C promoter polymorphism of the interleukin-6 gene and progression of prostate cancer in North Indian population. DNA and Cell Biology. 2008.  27, 505-510. [PubMed]
43. Kesarwani, P., Singh, R. and Mittal, R. D.  Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk. Archives of Toxicology. 2009.  83, 351-356. [PubMed]
44. Ahirwar, D., Kesarwani, P., Manchanda, P. K., Mandhani, A. and Mittal, R. D.  Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guerin immunotherapy in bladder cancer. Cancer Genetics and Cytogenetics. 2008.  184, 1-8. [PubMed]
45. Mittal, R. D., Singh, R., Manchanda, P. K., Ahirwar, D., Gangwar, R., Kesarwani, P. and Mandhani, A.  XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biology & Therapy. 2008.  7, 645-650. [PubMed]
46. Mittal, R. D., Bid, H. K., Manchanda, P. K. and Kapoor, R.  Association of interleukin-1beta gene and receptor antagonist polymorphisms with calcium oxalate urolithiasis. Journal of Endourology / Endourological Society. 2007.  21, 1565-1570. [PubMed]
47. Manchanda, P. K. and Mittal, R. D.  Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Molecular and Cellular Biochemistry. 2008.  311, 57-65. [PubMed]
48. Mittal, R. D. and Srivastava, D. L.  Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA and Cell Biology. 2007.  26, 791-798. [PubMed]
49. Mittal, R. D., Manchanda, P. K., Bid, H. K. and Ghoshal, U. C.  Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. Journal of Gastroenterology and Hepatology. 2007.  22, 920-924. [PubMed]
50. Mittal, R. D. and Manchanda, P. K.  Is low-frequency distribution of TGF-beta genotype associated with increased risk for end-stage renal disease? DNA and Cell Biology. 2007.  26, 172-177. [PubMed]
51. Mittal, R. D., Bid, H. K. and Manchanda, P. K.  Genotype and haplotype determination of IL1B (g. -511C>T and g. +3954C>T) and (IL1RN) in pediatric nephrolithiasis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2007.  379, 42-47. [PubMed]
52. Mittal, R. D., Mishra, D. K., Thangaraj, K., Singh, R. and Mandhani, A.  Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population? Steroids. 2007.  72, 335-341. [PubMed]
53. Mittal, R. D. and Manchanda, P. K.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics. 2007.  59, 159-165. [PubMed]
54. Mittal, R. D., Srivastava, D. S. and Mishra, D. K.  Is urokinase gene 3'-UTR polymorphism associated with prostate cancer? Cancer Biomarkers : Section A of Disease Markers. 2005.  1, 287-292. [PubMed]
55. Mittal, R. D., Mishra, D. K. and Mandhani, A.  Evaluating polymorphic status of glutathione-S-transferase genes in blood and tissue samples of prostate cancer patients. Asian Pacific Journal of Cancer Prevention : APJCP. 2006.  7, 444-446. [PubMed]
56. Manchanda, P. K., Bid, H. K. and Mittal, R. D.  Association of Urokinase Gene 3'-UTR T/C polymorphism with bladder cancer. Urologia Internationalis. 2006.  77, 81-84. [PubMed]
57. Manchanda, P. K., Kumar, A., Bid, H. K. and Mittal, R. D.  Interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility To Chemicals. 2006.  11, 164-173. [PubMed]
58. Bid, H. K., Manchanda, P. K. and Mittal, R. D.  Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology. 2006.  67, 1099-1104. [PubMed]
59. Manchanda, P. K., Bid, H. K., Kumar, A. and Mittal, R. D.  Genetic association of interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients. Transplant Immunology. 2006.  15, 289-296. [PubMed]
60. Manchanda, P. K., Kumar, A., Kaul, A. and Mittal, R. D.  Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2006.  370, 152-157. [PubMed]
61. Mittal, R. D., Bid, H. K., Kumar, A. and Bhandari, M.  Association of urokinase gene 3'-UTR polymorphism with calcium oxalate nephrolithiasis. Journal of Endourology / Endourological Society. 2006.  20, 157-160. [PubMed]
62. Bid, H. K., Mishra, D. K. and Mittal, R. D.  Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pacific Journal of Cancer Prevention : APJCP. 2005.  6, 147-152. [PubMed]
63. Srivastava, D. S. and Mittal, R. D.  Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population. BMC Urology. 2005.  5, 12. [PubMed]
64. Srivastava, D. S., Mishra, D. K., Mandhani, A., Mittal, B., Kumar, A. and Mittal, R. D.  Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. European Urology. 2005.  48, 339-344. [PubMed]
65. Mishra, D., Thangaraj, K., Mandhani, A., Kumar, A. and Mittal, R.  Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clinical Genetics. 2005.  68, 55-60. [PubMed]
66. Mishra, D. K., Bid, H. K., Srivastava, D. S., Mandhani, A. and Mittal, R. D.  Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urologia Internationalis. 2005.  74, 315-318. [PubMed]
67. Bid, H. K., Chaudhary, H. and Mittal, R. D.  Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatric Nephrology. 2005.  20, 773-776. [PubMed]
68. Mittal, R. D., Srivastava, D. S., A, M. and B, M.  Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pacific Journal of Cancer Prevention : APJCP. 2005.  6, 6-9. [PubMed]
69. Bid, H. K., Kumar, A., Kapoor, R. and Mittal, R. D.  Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. Journal of Endourology / Endourological Society. 2005.  19, 111-115. [PubMed]
70. Bid, H. K. and Mittal, R. D.  Internet resources and urology. Urologia Internationalis. 2005.  74, 1-12. [PubMed]
71. Mittal, R. D., Srivastava, D. S. and Mandhani, A.  NAT2 gene polymorphism in bladder cancer: a study from North India. International Braz J Urol. 2004.  30, 279-364. [PubMed]
72. Vaish, M., Mandhani, A., Mittal, R. D. and Mittal, B.  Microsatellite instability as prognostic marker in bladder tumors: a clinical significance. BMC Urology. 2005.  5, 2. [PubMed]
73. Srivastava, D. S., Mandhani, A., Mittal, B. and Mittal, R. D.  Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU International. 2005.  95, 170-173. [PubMed]
74. Kumar, R., Ghoshal, U. C., Singh, G. and Mittal, R. D.  Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation. Journal of Gastroenterology and Hepatology. 2004.  19, 1403-1409. [PubMed]
75. Mittal, R. D., Singh, G., Srivastava, A., Pradhan, M., Kesari, A., Makker, A. and Mittal, B.  Y chromosome micro-deletions in idiopathic infertility from Northern India. Annales De Genetique. 2004.  47, 331-337. [PubMed]
76. Mishra, D. K., Kumar, A., Srivastava, D. S. and Mittal, R. D.  Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pacific Journal of Cancer Prevention : APJCP. 2004.  5, 362-365. [PubMed]
77. Mittal, R. D., Srivastava, D. S., Mandhani, A., Kumar, A. and Mittal, B.  Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India. Indian Journal of Cancer. 2004.  41, 115-119. [PubMed]
78. Mittal, R. D. and Kumar, R.  Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. Journal of Endourology / Endourological Society. 2004.  18, 418-424. [PubMed]
79. Srivastava, D. S., Kumar, A., Mittal, B. and Mittal, R. D.  Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Archives of Toxicology. 2004.  78, 430-434. [PubMed]
80. Mittal, R. D., Kumar, R., Mittal, B., Prasad, R. and Bhandari, M.  Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 2003.  12, 208-213. [PubMed]
81. Kumar, R., Mukherjee, M., Bhandari, M., Kumar, A., Sidhu, H. and Mittal, R. D.  Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. European Urology. 2002.  41, 318-322. [PubMed]
82. Chaturvedi, L. S., Srivastava, S., Mukherjee, M., Mittal, R. D., Phadke, S. R., Pradhan, S. and Mittal, B.  Carrier detection in non-deletional Duchenne/Becker muscular dystrophy families using polymorphic dinucleotide (CA) repeat loci of dystrophin gene. The Indian Journal of Medical Research. 2001.  113, 19-25. [PubMed]
83. Sinha, S., Mishra, S., Singh, V., Mittal, R. D. and Mittal, B.  High frequency of new mutations in North Indian Duchenne/Becker muscular dystrophy patients. Clinical Genetics. 1996.  50, 327-331. [PubMed]

 
Grant Support:
Project Title Role Funding Agency Sanction Number Sanction Date
Role of Caspase Genes Polymorphism and TNF Alpha induced Apoptosis in Prostate Cancer Susceptibility, Possible induction to Hormone Refractory Possible Cancer Principal Investigator Council of Science and Technology, Uttar Pradesh, India 2010
Clinical outcome of bacillus calmetteguerin (BCG) immunotherapy in superficial bladder cancer modulated by genetic variations Department of Science & Technology, Government of India 2009-2012
Study of cytokine gene Polymorphisms in Renal Transplantation and its Association with Acute/Chronic Allograft Rejection Council of Scientific and Industrial Research, Government of India 2008-2011
Pharmacogenetics of calcineurin inhibitor (Cycloporin) in renal transplant recipients from North India Department of Biotechnology, Government of India 2008-2011
Molecular Analysis of calcium oxelate stone Disease Department of Science & Technology, Government of India 2001-2003
Relative role of intrinsic versus extrinsic factors in the etiopathogenesis of calcium oxalate Urolithiasis Council of Science and Technology, Uttar Pradesh, India 2000-2002

 
 
 
Education 
::
Ph.D.
Honors and Awards
::
2000, Award by American Association for Clinical Chemistry
Type of Neoplasms
Male genital system
Prostate
  Last modified on : Dec 16, 2015
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.